Health Risk Assessment of Contaminated Sites: Technical Framework, Testing, and Applications

Health risk assessment of contaminated sites is a systematic, standards-based process that quantifies the potential adverse human health effects arising from exposure to hazardous substances in soil, groundwater, soil gas, and other environmental media. It provides the scientific basis for deriving site-specific remediation goals, supporting brownfield redevelopment, and demonstrating regulatory compliance under frameworks such as ASTM E1739, US EPA RAGS, GB 36600-2018, and HJ 25.3. Accredited third-party laboratories supply the sampling, chemical analysis, and risk modeling expertise required to produce defensible assessments for industrial, commercial, and residential land uses.

Technical Overview

Health risk assessment of contaminated sites is a quantitative, science-driven evaluation of the likelihood that hazardous substances present in soil, groundwater, soil gas, or other environmental media will cause adverse health effects in current or future site receptors. It is applied to former manufacturing plants, chemical storage facilities, fuel stations, landfills, mining areas, and agricultural land where releases of contaminants may have occurred. The assessment converts measured contaminant concentrations into estimates of exposure and risk, enabling risk-based corrective action and land-management decisions rather than reliance on generic, often overly conservative, cleanup values.

The assessment follows the four-step paradigm established by the US EPA Risk Assessment Guidance for Superfund (RAGS) and adopted by most international regulatory frameworks:

• Hazard identification: review of site history, prior investigation data, and site reconnaissance to determine which contaminants of potential concern (COPCs) are present and at what concentrations.
• Exposure assessment: development of a conceptual site model (CSM) defining contaminant sources, release mechanisms, transport pathways, exposure routes (oral ingestion, dermal contact, inhalation of vapors and particulates), and receptor populations for current and reasonable future land uses.
• Toxicity assessment: assignment of dose-response relationships, including cancer slope factors (oral and inhalation), reference doses (RfD), and reference concentrations (RfC), for each COPC.
• Risk characterization: calculation of chronic daily intakes (CDI), carcinogenic risk (CR) as an incremental lifetime cancer risk, and non-carcinogenic hazard quotients (HQ) aggregated into a hazard index (HI) for each exposure pathway and receptor.

Most regulatory programs consider a carcinogenic risk below 1 × 10⁻⁶ (one excess cancer case per million exposed individuals) to be negligible, with values up to 1 × 10⁻⁴ acceptable in some jurisdictions, and require a hazard index not exceeding 1 for non-carcinogenic endpoints. Relevant standards and guidance include ASTM E1739 and ASTM E2081 (Risk-Based Corrective Action), US EPA RAGS Parts A–F, ISO 15800 and ISO 15175 on soil contamination characterization, GB 36600-2018 on risk control standards for development land, HJ 25.3-2019 on risk assessment of soil contamination of land for construction, and the ISO 18400 series for soil sampling.

Testing Samples

Soil Samples

Surface soil (typically 0–0.5 m) and subsurface soil cores are collected from boreholes or test pits positioned on a grid or judgmentally based on the conceptual site model. Discrete samples are taken at stratigraphic boundaries and zones of visible staining or elevated photoionization detector (PID) readings. Samples for volatile organic compound (VOC) analysis are collected with minimal disturbance using methanol preservation or dedicated EnCore-type samplers, while samples for metals and semi-volatiles are placed in wide-mouth glass jars with Teflon-lined caps and cooled to 4 °C under full chain-of-custody documentation.

Groundwater Samples

Groundwater is collected from permanent monitoring wells or temporary direct-push wells screened across the water table or targeted depth intervals. Low-flow (minimal drawdown) purging is performed with field monitoring of pH, conductivity, dissolved oxygen, redox potential, and turbidity until stabilization. VOC samples are collected in zero-headspace vials; samples for dissolved metals are field-filtered through 0.45 µm membranes.

Soil Gas and Air Samples

For vapor intrusion evaluation, sub-slab soil gas probes, near-slab exterior soil gas points, and occasionally indoor air samples are collected. Soil gas is withdrawn into evacuated stainless-steel canisters or onto sorbent tubes and analyzed for volatile compounds relevant to the subsurface contamination, with leak checks and tracer tests performed during sampling.

Sediment and Surface Water Samples

Where a site adjoins rivers, lakes, or coastal waters, sediment grabs or cores and surface water samples are collected to complete the conceptual site model and evaluate migration of contaminants off site.

Testing Items

The contaminant list is tailored to site history and the conceptual site model, but typical testing programs include the following categories:

• Metals and metalloids: arsenic, cadmium, total and hexavalent chromium, lead, mercury, copper, nickel, zinc, beryllium, antimony, selenium, thallium, cobalt, vanadium, and molybdenum.
• Volatile organic compounds (VOCs): benzene, toluene, ethylbenzene, xylenes, trichloroethylene, tetrachloroethylene, carbon tetrachloride, chloroform, 1,2-dichloroethane, 1,1,1-trichloroethane, vinyl chloride, and related solvents.
• Semi-volatile organic compounds (SVOCs): the priority polycyclic aromatic hydrocarbons (including benzo[a]pyrene and naphthalene), phenols, nitrobenzene and nitroaromatics, anilines, and phthalate esters.
• Persistent organic pollutants: polychlorinated biphenyls (PCBs), organochlorine pesticides (DDT, hexachlorocyclohexane, aldrin, dieldrin, chlordane), organophosphorus pesticides, and dioxins and furans.
• Petroleum hydrocarbons: total petroleum hydrocarbons (TPH), fractionated aliphatic and aromatic hydrocarbons, BTEX, and fuel oxygenates such as MTBE.
• Emerging contaminants: per- and polyfluoroalkyl substances (PFAS), 1,4-dioxane, and other substances of evolving regulatory concern.
• Supporting parameters for risk modeling: pH, soil organic carbon content, moisture content, bulk density, grain size distribution, hydraulic conductivity, and groundwater geochemical indicators.

Testing Methods

All sampling and analytical work follows documented international and national standards, executed by ISO/IEC 17025-accredited third-party laboratories:

• Sampling protocols: ISO 18400 series for soil sampling, ASTM D6169 for sampling design, US EPA field sampling procedures, and ASTM D7758 for soil gas monitoring.
• Metals: acid or microwave digestion (US EPA 3050B / 3051A) followed by ICP-MS (US EPA 6020B, ISO 17294-2), ICP-OES (US EPA 6010D, ISO 11885), or atomic absorption spectrometry; mercury by thermal decomposition (US EPA 7473); hexavalent chromium by alkaline digestion (US EPA 3060A) with colorimetric or ion-chromatographic determination.
• VOCs: purge-and-trap GC-MS (US EPA 8260D, ISO 15680) or headspace GC-MS (US EPA 5021A); soil gas and ambient air by GC-MS per US EPA TO-15 and TO-17.
• SVOCs and PAHs: solvent extraction followed by GC-MS (US EPA 8270E, ISO 18287) or HPLC with fluorescence detection.
• PCBs and pesticides: GC-ECD or GC-MS (US EPA 8082A, US EPA 8081B).
• Petroleum hydrocarbons: GC-FID (US EPA 8015C) with silica-gel cleanup and fractionation where toxicity-based fractions are required.
• Dioxins and furans: high-resolution GC-MS by isotope dilution (US EPA 1613B).
• PFAS: LC-MS/MS (US EPA 537.1 and US EPA 533 for water; US EPA 1633 for soils and other matrices).
• Field screening: portable XRF (US EPA 6200) for metals and PID/FID instruments for VOCs to support adaptive, real-time sampling decisions.

Quality assurance and quality control measures include method blanks, laboratory control samples, matrix spikes and duplicates, surrogate recoveries, calibration verification, and verification of holding times, with method detection limits set below the applicable screening values. Datasets undergo formal validation before being used in exposure and risk calculations to ensure the defensibility of the conclusions.

Applications

Health risk assessment of contaminated sites supports a wide range of environmental and business decisions:

• Brownfield redevelopment and land-use conversion, particularly the change of industrial land to residential or educational use where child receptors and conservative exposure assumptions apply.
• Derivation of site-specific remediation targets as an alternative to generic screening values in GB 36600-2018 and comparable national or provincial standards.
• Environmental due diligence for real estate transactions and mergers and acquisitions, complementing Phase II environmental site assessments conducted under ASTM E1903.
• Remediation design, verification sampling, and regulatory closure or sign-off for soil and groundwater cleanup projects.
• Vapor intrusion evaluation for occupied buildings and the specification of mitigation measures such as vapor barriers and sub-slab depressurization systems.
• Long-term risk management, including institutional controls, land-use restrictions, and monitored natural attenuation strategies.
• Support for environmental litigation, insurance claims, and cost allocation between responsible parties.
• Risk communication to regulators, investors, and communities regarding the safety of a site for its intended use.

FAQ

What is the difference between generic screening values and a site-specific health risk assessment?

Generic screening values are conservative, default-based concentrations intended for initial screening and may flag risks that do not actually exist at a specific site. A site-specific assessment incorporates actual soil properties, hydrogeology, building conditions, and land-use scenarios, frequently producing less conservative yet scientifically defensible cleanup goals that can substantially reduce remediation costs.

What risk levels are considered acceptable?

Most frameworks treat a carcinogenic risk below 1 × 10⁻⁶ as negligible, with acceptable risk thresholds extending to 1 × 10⁻⁴ under certain regulatory programs, while non-carcinogenic effects are considered acceptable when the hazard index remains at or below 1 for each receptor and pathway.

Which exposure pathways are typically evaluated?

Standard pathways include direct ingestion of soil and dust, dermal contact with soil, inhalation of soil vapor migrating into indoor air, inhalation of wind-blown particulates, and ingestion of groundwater used as a drinking water source. Children are generally the most sensitive receptors and typically govern the assessment outcome for residential land use.

How long does a health risk assessment take?

A screening-level assessment using existing data may be completed within one to two weeks. A full site-specific assessment involving intrusive investigation, laboratory analysis, conceptual site model development, and risk calculation typically requires several weeks to a few months, depending on site complexity and data gaps.

What happens if calculated risks exceed the acceptable thresholds?

Where risks exceed thresholds, options include remediation of soil or groundwater to the derived cleanup levels, engineering controls such as vapor barriers or sub-slab depressurization systems, institutional controls restricting land use, or a refined assessment using additional site data to reduce uncertainty in the risk estimates.

Are the results accepted by regulators?

Yes. When sampling and analysis are performed by accredited third-party laboratories under documented QA/QC procedures and the assessment follows applicable national standards such as GB 36600-2018, HJ 25.3-2019, or internationally recognized frameworks such as ASTM E1739 and US EPA RAGS, the results are accepted by environmental authorities for compliance determination and site closure decisions.